Azfar Zaman

Azfar Zaman

Interventional cardiologist / Cardiologist
Freeman Hospital - Newcastle Upon Tyne, United Kingdom

Latest contributions

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

High-risk PCI in acute coronary syndrome

22 May 2025 – From EuroPCR 2025

Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.

High-risk PCI in acute coronary syndrome

Heart team discussion for left main PCI

14 May 2024 – From EuroPCR 2024

This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....

Heart team discussion for left main PCI

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Treating patients with drug-coated balloons – what is the optimal result?

12 Apr 2024

Watch this webinar with F. L. Ribichini, F. Alfonso, C. C. Frankie Tam and A. G. Zaman on how to prepare lesions for drug-coated ballons-based PCI and much more!

#1 - How should I treat a patient with in-stent restenosis ?

31 Oct 2022

Discover the replay of this PCR Webinar on drug-coated-balloons with F. Ribichini, B. Scheller and A. G. Zaman

Trade-off decisions in patients at high bleeding risk

02 May 2021

Discover the replay of this webinar on high bleeding risk and complex PCI, with D. Capodanno, R. Colleran, C. Naber and A. Zaman.

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

Ultrathin struts (60µ) for all diameter and lengths of stents, will that improve outcome

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the new highly deliverable 60 micron Ultrathin biodegradable polymer DES- Supraflex Cruz and how it may address the unmet needs, thanks to up-to-date clinical data.

Ultrathin struts (60µ) for all diameter and lengths of stents, will that improve outcome